OPTIMIZATION OF THE DIFFERENTIATED HORMONAL AND METABOLIC THERAPY BY THE FE-MALE PATIENTS OF THE CHILDBEARING AGE WITH ENDOMETRIAL HYPERPLASIA

In this article the treatment methods of endometrial hyperplasia by women of the childbearing age, directed on the elimination of metabolic and endocrine violations, are described. The use of the offered treatment schemes gives the chance to create groups of risk on an endometrial hyperplasia recurrent based on the developed diagnostic criteria characterizing the separate pathogenetic unit of prooxidant-antioxidant status, and promptly to carry out the correc-tion, optimizing hormonal regulation, for ensuring of state normalization of endometrium, for decrease in frequency of repeated episodes of disease and improvement of fertility.